Only the COOH-terminal fragment of CXCL4 decreased MDA-MB-231 tumor growth, not through inhibition of angiogenesis but rather by eliciting an anti-tumoral immune response and by inhibiting tumor cell proliferation. This evidence concerns the gene PF4 and neoplasm.